Under the pan-Canadian Pharmaceutical Alliance framework, the maximum public drug plan price for generic semaglutide is approximately $114 per four-week supply with two manufacturers approved, dropping to roughly $80 once a third manufacturer launches
Calcium may help prevent low bone density
Comparing Long-Term GLP-1 Options to Avoid the Stop-and-Regain Cycle Wegovy is effective but expensive and sometimes subject to supply constraints
Treatment eligibility, pricing, medication availability, dosing, pharmacy preparation, and results vary based on individual medical evaluation, provider assessment, treatment goals, and clinical appropriateness
The GLP-1 Bridge program will cover three drugs, Foundayo, Wegovy and Zepbound, and be available to people who have Medicare Part D, an optional extra coverage to lower the cost of prescriptions
In the case of weight loss, a physician-supervised weight loss program will be the most effective way to lose weight and keep it off long-term